F-star Therapeutics, Inc.
5 clinical trials · Sponsor
◉ Watch F-star Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus (NCT04059198) | F-star Therapeutics, Inc. | 2019-10-10 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor (NCT04023721) | F-star Therapeutics, Inc. | 2019-06-18 |
| Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients (NCT03932513) | F-star Therapeutics, Inc. | 2019-04-11 |
| A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects (NCT03493698) | F-star Therapeutics, Inc. | 2018-05-07 |
Track F-star Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.